Reports for GLENMARK PHARMACEUTICALS CANADA INC.

Company Name
GLENMARK PHARMACEUTICALS CANADA INC.

Shortage reports

Actual shortage:

11 (37%)

Anticipated shortage:

0 (0%)

Avoided shortage:

0 (0%)

Resolved:

19 (63%)

30

Discontinuation Reports

To be discontinued:

0

Discontinued:

0

Reversed:

0

0

10 (33%)

4 (36%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
GLN-URSODIOL 250MG TABLET Resolved 2024-11-07 2024-12-23 242232
GLN-URSODIOL 500MG TABLET Resolved 2024-11-07 2024-12-23 242235
MAEVE 0.35MG TABLET Actual shortage 2026-02-13 2026-03-17 278123
STRAMUCIN 2% CREAM Actual shortage 2025-07-17 2026-03-17 262959
STRAMUCIN 2% CREAM Resolved 2025-03-18 2025-05-08 252945
STRAMUCIN 2% CREAM Resolved 2025-01-17 2025-03-17 247973
STRAMUCIN 2% CREAM Resolved 2024-12-05 2025-03-17 244858
TRI-JORDYNA 21 0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG TABLET Actual shortage 2025-12-09 2026-03-17 273867
URSODIOL TABLETS USP 500MG TABLET Resolved 2017-11-28 2018-01-02 30989
URSODIOL TABLETS USP 250MG TABLET Resolved 2017-11-28 2018-01-02 30985

Showing 21 to 30 of 30

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0